Multiple system atrophy: Cellular and molecular pathology

Journal of Clinical Pathology - Molecular Pathology

Volumn 54, Issue 6, 2001, Pages 419-426

  Burn, D J ^a   Jaros, E ^a  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

synuclein; Glial cytoplasmic inclusion; Multiple system atrophy; Oligodendrocyte

Indexed keywords

ALPHA SYNUCLEIN; CYTOSKELETON PROTEIN;

CELL INCLUSION; DEATH; DEGENERATIVE DISEASE; DIFFUSE LEWY BODY DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; ENVIRONMENTAL FACTOR; FAMILIAL DISEASE; FIBROGENESIS; GLIA CELL; HALLERVORDEN SPATZ DISEASE; HUMAN; IMMUNOHISTOCHEMISTRY; INCIDENCE; LEWY BODY; NERVE FIBER; NEUROPATHOLOGY; OLIGODENDROGLIA; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; SHY DRAGER SYNDROME; THERAPY RESISTANCE;

AGED; ALPHA-SYNUCLEIN; AUTONOMIC NERVOUS SYSTEM; AXONS; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL DEATH; EXTRACELLULAR MATRIX; FEMALE; HUMANS; INCLUSION BODIES; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; NERVE TISSUE PROTEINS; NEURONS; OLIGODENDROGLIA; POLYMORPHISM, GENETIC; SYNUCLEINS;

EID: 0035666667     PISSN: 13668714     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (92)

1. Prevalence of progressive supranuclear palsy and multiple system atrophy: A cross-sectional study
2. Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy
3. Consensus statement on the diagnosis of multiple system atrophy
4. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy Drager syndrome)
5. Argyrophilic ubiquitinated cytoplasmic inclusions of Leu-7-positive glial cells in olivopontocerebellar atrophy (multiple system atrophy)
6. Accumulation of tubular structures in oligodendroglial and neuronal cells as the basic alteration in multiple system atrophy
7. NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy
8. Multiple-system atrophy: A new alpha-synuclein disease?
9. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein
10. Accumulation of alpha-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy
11. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies
12. Neurodegeneration with brain iron accumulation, type 1 is characterized by alpha-, beta-, and gamma-synuclein neuropathology
13. Parkinsonism. Multiple system atrophy
14. Multiple system atrophy
15. Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: A clinicopathological study
16. Multiple system atrophy: A review of 203 pathologically proven cases
17. Potential selection bias in autopsy series of Parkinson's disease and related disorders
18. Survival of patients with pathologically proven multiple system atrophy: A meta-analysis
19. Multiple sictem atrophy: A sporadic synucleinopathy
20. The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology
21. The distribution and dynamic density of oligodendroglial cytoplasmic inclusions (GCIs) in multiple system atrophy: A correlation between the density of GCIs and the degree of involvement of striatonigral and olivopontocerebellar systems
22. Cell death mechanisms in multiple system atrophy
23. Cellular pathology of multiple system atrophy: A review
24. Multiple system atrophy with remarkable frontal lobe atrophy
25. Asymmetrical temporal lobe atrophy with massive neuronal inclusions in multiple system atrophy
26. Widespread alterations of alpha-synuclein in multiple system atrophy
27. Myelin degeneration in multiple system atrophy detected by unique antibodies
28. Constant involvement of the Betz cells and pyramidal tract in multiple system atrophy: A clinicopathological study of seven autopsy cases
29. Quantitative study of lateral horn cells in 15 cases of multiple system atrophy
30. Depletion of catecholaminergic neurons of the rostral ventrolateral medulla in multiple systems atrophy with autonomic failere
31. Striatonigral degeneration: A clinicopathological study
32. Dopa resictance in multiple system atrophy: Loss of dopamine D2 receptors
33. Striatal efferent involvement and its correlation to levodopa efficacy in patients with multiple system atrophy
34. "Minimal change" multiple system atrophy
35. Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11 C-raclopride and positron emission tomography
36. Multiple system atrophy: Sporadic or familial?
37. Environmental-occupational risk factors and familial associations in multiple syctem atrophy: A preliminary investigation
38. A novel cytochrome P-450IID6 (CYPIID6) mutant gene associated with multiple system atrophy
39. Arg29 to Cys296 polymorphism in exon 6 of cytochrome P-450-2D6 (CYP2D6) is not associated with multiple system atrophy
40. Apoprotein E e4 allele frequency in patients with multiple system atrophy
41. Multiple-sysdem atrophy ic genetically distinct from identified inherited causes of spinocerebellar degeneration
42. No mutation in the entire coding region of the alpha-synuclein gene in pathologically confirmed cases of multiple system atrophy
43. Mutation screening in the α-synuclein gene in MSA
44. Mutation screening in exons 3 and 4 of alpha-synuclein in sporadic Parkinson's and sporadic and familial dementia with Lewy bodies cases
45. Increased susceptibility to sporadic Parkinson's disease by a certain combined a-synuclein/apolipoprotein E genotype
46. Synphilin-1 associates with a-synuclein and promotes the fobmadion of cytosolic inclusions
47. α-Synuclein shares physical and functional homology with 14-3-3 proteins
48. Cloning and mapping of ZNF231, a novel brain-specific gene encoding neuronal double zinc finger protein whose expression is enhanced in a neurodegenerative disorder, multiple system atrophy (MSA)
49. Immunocytochemical and ultrastructural studies of neuronal and oligodendroglial cytoplasmic inclusions in multiple system atrophy. 1. Neuronal cytoplasmic inclusions
50. Immunocytochemical and ultrastructural studies of neuronal and oligodendroglial cytoplasmic inclusions in multiple system atrophy. 2. Oligodendroglial cytoplasmic inclusions
51. Multiple system atrophy: Clues from inclusions
52. Glial inclusions in CNS degenerative diseases
53. Tau protein in the glial cytoplasmic inclusions of multiple system atrophy can be distinguished fbom abnormal tau in Alzheimer's disease
54. Cytoskeletal abnormalities in patients with olivopontocerebellar atrophy - An immunocytochemical and Gallyas impregnation study
55. Cyclindependent kinase 5 and mitogen-activated protein kinase in glial cytoplasmic inclusions in multiple system atrophy
56. Alpha-synuclein immunoisolation of glial inclusions from multiple system atrophy brain tissue reveals multiprotein components
57. Small heat shock proteins, the cytoskeleton, and inclusion body formation
58. Ubiquitin, cellular inclusions and their role in neurodegeneration
59. Identification of two distinct synucleins from human brain
60. NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded
61. Human recombinant NACP/α-synuclein is aggregated and fibrillated in vitro. Relevance for Lewy body disease
62. Mutant and wild type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro
63. Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro
64. The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity
65. Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia
66. Iron acquisition and expression of iron regulatory proteins in the developing brain: Manipulation by ethanol exposure, iron deprivation and cellular dysfunction
67. Immunohistochemical and biochemical studies demonstrate a distinct profile of alpha-synuclein permutations in multiple system atrophy
68. Midkine, a new neurotrophic factor, is present in glial cytoplasmic inclusions of multiple system atrophy brains
69. Pleiotrophin and midkine, a family of mitogenic and angiogenic heparin-binding growth and differentiation factors
70. Midkine exists in astrocytes in the early stage of cerebral infarction
71. Alpha-synuclein is developmentally expressed in cultured rat brain oligodendrocytes
72. Expression of microtubule-associated proteins MAP2 and tau in cultured rat brain oligodendrocytes
73. Microtubule-associated proteins in developing oligodendrocytes: Transient expression of a MAP2c isoform in oligodendrocyte precursors
74. Expression of the endocytosis regulatory proteins Rab5 and Rabaptin-5 in glial cytoplasmic inclusions from brains with multiple system atrophy
75. p53- and CD95-associated apoptosis in neurodegenerative diseases
76. Altered expression of calcium- and apoptosis-regulating proteins in multiple system atrophy Purkinje cells
77. Caspases as treatment targets in stroke and neurodegenerative diseases
78. Involvement of caspase-3-like cysteine protease in 1-methyl-4-phenylpyridinium-mediated apoptosis of cultured cerebellar granule neurons
79. Is caspase-3 a vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease?
80. Microglial activation in multiple system atrophy: A potential role for NF-kappaB/rel proteins
81. In vivo imaging of activated microglia with [11C]PK11195 positron emission tomography in patients with multiple system atrophy
82. Brain-derived neurotrophic factor in the control of human brain, and in Alzheimer's disease and Parkinson's disease
83. Increased brain-derived neurotrophic factor-containing axons in the basal ganglia of patients with multiple system atrophy
84. Cell death and control of cell survival in the oligodendrocyte lineage
85. Neuregulins and their receptors: A versatile signalling molecule in organogenesis and oncogenesis
86. GGF/neuregulin induces a phenotypic reversion of oligodendrocytes
87. A role of the acetylcholine receptor-inducing protein in oligodendrocyte development
88. Integrins mediate neuronal survival signal for oligodendrocytes
89. Laminin-like proteins are differentially regulated during cerebellar development and stimulate granule cell neurite outgrowth in vitro
90. Laminin-2/integrin interactions enhance myelin membrane formation by oligodendrocytes
91. Laminins of the adult mammalian CNS; laminin-α2 (Merosin M-) chain immunoreactiviry is associated with neuronal processes
92. Laminin-α2 chain-like antigens in CNS dendritic spines